🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations Layal Al Mahmasani on superb effort. Memorial Sloan Kettering Cancer Center MSK Department of Medicine proud of your #BiliaryTractCancer and #obesity self initiated, queried, and followed through from start to end effort . Unsurprisingly impressive!

Ghassan Abou-Alfa Eileen M O’Reilly Memorial Sloan Kettering Cancer Center MSK Department of Medicine ASCO Our brilliant and compassionate oncologist, Eileen M O’Reilly! We were so lucky & blessed to have had her treat my husband’s PDAC. Thank you both, Ghassan Abou-Alfa, for all you do to improve public health worldwide.

Cholangiocarcinoma Awareness Month Craine’s Cholangiocarcinoma Crew Memorial Sloan Kettering Cancer Center Ghassan Abou-Alfa Global Cholangiocarcinoma Alliance Cholangiocarcinoma Foundation Cholangiocarcinoma Foundation WorldCCADay

Cholangiocarcinoma Awareness Month Memorial Sloan Kettering Cancer Center Ghassan Abou-Alfa Global Cholangiocarcinoma Alliance Craine’s Cholangiocarcinoma Crew Cholangiocarcinoma Foundation WorldCCADay CURE - Research Project

Congtatulations Blue Faery on continued incredible effort for all dear #HCC patients and their loved ones. It was Ghassan Abou-Alfa Memorial Sloan Kettering Cancer Center MSK Department of Medicine to connect during @asco #GI25

Whether preparing for board certification or seeking a thorough review, don’t miss the 13th Annual Board Review and Comprehensive Update in #Hematology & #MedicalOncology this March. This intensive 3.5-day virtual course delivers an up-to-date, expert-led review. Learn more:

Thank you Rizzo et al. This is an invitation for more very much needed collaborative work in cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: the real challenge? - ESMO Open esmoopen.com/article/S2059-…

Thanks Memorial Sloan Kettering Cancer Center MSK Department of Medicine Leonard Saltz on insightful discussion of rectal cancer case. Ghassan Abou-Alfa 17th year of monthly fellows' based GI cancer case discussion. We sure learn the advances of care but strategic thinking is key. Medicine is an Art!

Data from #HIMALAYA presented today by #BrunoSangro + Ghassan Abou-Alfa in the EASLnews #LiverCancerSummit 👉Look at “time to first subsequent line of therapy (TFST 📸4)”-favours #DurvaTreme 🧐Could #TFST capture treatment-derived #benefit better than PFS? 🧩Did we solve the riddle?

Treatment Innovation in #BiliaryTractCancer: Gain insights into biomarker testing, guidelines, & the safety and efficacy for BTC treatment platform with Drs. Arndt Vogel, James J. Harding, MD, & Ghassan Abou-Alfa. Produced with Cholangiocarcinoma Foundation. bit.ly/3ANZikM

Value of academic merit: To agree and disagree. Solid arguments by Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa CUHK Medicine stephen chan and Humanity & Health Clinical Trial Centre George Lau in reply to: STRIDE's Efficacy and Safety in Asian Hepatocellular Carcino... sciencedirect.com/science/articl…

We're excited to kick off the Memorial Sloan Kettering Cancer Center 2025 Update in #Hematology and #MedicalOncology and 13th Annual Board Review this Friday. Join us for an engaging program led by renowned faculty. Explore the full agenda at bit.ly/HemOnc2025. #MSKHemOncCME ILSON David,

Congratulations The National Pancreas Foundation . What an honor and delight for Memorial Sloan Kettering Cancer Center MSK Department of Medicine Eileen M O’Reilly to chair and lead your efforts for better science and care of all #pancreaticcancer patients worldwide

Congratulations Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Radiation Oncology Christopher Crane! Thanks The National Pancreas Foundation!

Join us April 23, for a live virtual expert-led cancer IO program, ACI: A Focus on Gastrointestinal Cancers. Discuss ongoing studies of adoptive cellular therapies for gastrointestinal cancer. Register now: ow.ly/UKB250VjSPB Ghassan Abou-Alfa Gregory Lesinski #LearnACI

Working on Her2 discussions. A few things to keep in🧠: HER2 definition/approvals/response rates differ. - Overexpression: IHC 3+ - Amplification: FISH (HER2/CEP17 ratio ≥2 or >6 copies) - Mutation: on NGS ERBB2 (Exon 20 insertion most common) #OncTwitter #lcsm #gism #bcsm

Congratulations and thank you Memorial Sloan Kettering Cancer Center MSK Department of Medicine James J. Harding, MD Aruj Dhayni and Richard K.G. Do and Jinru Shia for a superb case discussion of a case of #gallbladdercancer with #her2 positive disease.

‘I Have Cancer,’ the TikTok Star Said. Then Came the Torrent of Hate. - The New York Times. Memorial Sloan Kettering Cancer Center ⁦MSK Department of Medicine⁩ Ghassan Abou-Alfa are proud of you Sydney. Thank you for coming forward with this message of love humanity in need for. Keep going! nytimes.com/2025/05/01/nyr…

I'm proud to say that Ghassan Abou-Alfa, who is featured very positively in this article, is a stunning 2024 graduate of Fordham Law ‘I Have Cancer,’ the TikTok Star Said. Then Came the Torrent of Hate. nytimes.com/2025/05/01/nyr…